A unique Swedish life science development company

    PULS turns life science projects into attractive business opportunities for the life science industry. Each project is based on a well-defined medical need. PULS secures long-term financing and world-class scientific and industrial expertise through joint ownership with innovators. Our track record validates all aspects of our business model – a model that serves both innovators and investors well. Try us!

    News from PULS

    25 January, 2017

    Sarah Fredriksson ny VD i P.U.L.S. AB

    Sarah Fredriksson har utsetts till ny VD i PULS och efterträder Pontus Ottosson. Hon kommer att tillträda sin befattning senast vid halvårsskiftet.

    1 December, 2016

    Recipharm and Laccure agree commercial collaboration

    Leading contract development and manufacturing organisation (CDMO) Recipharm is entering into a collaboration with Laccure AB for the commercial manufacture and delivery of Laccure® Pessary.

    Find out more
    Do you have an idea?
    Do you have the knowledge?
    Do you have the experience?

    © 2012-2017 P.U.L.S. AB | Kullagatan 8, 252 20 Helsingborg, Sweden | All rights reserved.